Media Contact
Amanda Galgay
Corporate Communications & Investor Relations
617-804-6659
amanda.galgay@peartherapeutics.com
Press Releases
- Pear Therapeutics to Present Data on reSET®, for the Treatment of Substance Use Disorder, and Pear-004, for the Treatment of Schizophrenia, at American Psychiatric Association Annual Meeting May 18, 2019
- Pear Therapeutics to Present at the Needham Emerging Technology Conference May 14, 2019
- Pear Therapeutics Initiates Feasibility Study to Treat Depressive Symptoms in People With Multiple Sclerosis May 3, 2019
- Pear Therapeutics to Participate in Goldman Sachs Digital Health: Biosensors, AI, and the Future of Data Analytics Conference and 26th Annual BioCentury Future Leaders in the Biotech Industry Conference April 4, 2019
- Pear Therapeutics to Present at Oppenheimer’s 29th Annual Healthcare Conference March 13, 2019
- Pear Therapeutics to Participate in 8th Annual SVB Leerink Global Healthcare Conference and Cowen and Company 39th Annual Healthcare Conference February 20, 2019